BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15595202)

  • 21. A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukaemia.
    Alexander DD; Mink PJ; Mandel JH; Kelsh MA
    Occup Med (Lond); 2006 Oct; 56(7):485-93. PubMed ID: 16905622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of latency period between benzene exposure and development of leukemia--a synopsis of literature.
    Triebig G
    Chem Biol Interact; 2010 Mar; 184(1-2):26-9. PubMed ID: 20026016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive review of occupational and general population cancer risk: 1,3-Butadiene exposure-response modeling for all leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, myeloid neoplasm and lymphoid neoplasm.
    Sielken RL; Valdez-Flores C
    Chem Biol Interact; 2015 Nov; 241():50-8. PubMed ID: 26070419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of follow-up time on risk estimates: a longitudinal examination of the relative risks of leukemia and multiple myeloma in a rubber hydrochloride cohort.
    Silver SR; Rinsky RA; Cooper SP; Hornung RW; Lai D
    Am J Ind Med; 2002 Dec; 42(6):481-9. PubMed ID: 12439871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
    Sanner T; Dybing E; Willems MI; Kroese ED
    Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cancer risk and exposure to 1,3-butadiene--a tale of mice and men.
    Stayner LT; Dankovic DA; Smith RJ; Gilbert SJ; Bailer AJ
    Scand J Work Environ Health; 2000 Aug; 26(4):322-30. PubMed ID: 10994798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response implications of the University of Alabama study of lymphohematopoietic cancer among workers exposed to 1,3-butadiene and styrene in the synthetic rubber industry.
    Sielken RL; Valdez-Flores C
    Chem Biol Interact; 2001 Jun; 135-136():637-51. PubMed ID: 11397418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure.
    Steenland K
    Am J Ind Med; 2005 Jul; 48(1):16-23. PubMed ID: 15940719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,3-Butadiene, styrene and lymphohaematopoietic cancers among North American synthetic rubber polymer workers: exposure-response analyses.
    Sathiakumar N; Bolaji BE; Brill I; Chen L; Tipre M; Leader M; Arora T; Delzell E
    Occup Environ Med; 2021 Dec; 78(12):859-868. PubMed ID: 34108254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicology and epidemiology of 1,3-butadiene.
    Himmelstein MW; Acquavella JF; Recio L; Medinsky MA; Bond JA
    Crit Rev Toxicol; 1997 Jan; 27(1):1-108. PubMed ID: 9115622
    [No Abstract]   [Full Text] [Related]  

  • 32. A hematology surveillance study of petrochemical workers exposed to 1,3 butadiene.
    Tsai SP; Ahmed FS; Ransdell JD; Wendt JK; Donnelly RP
    J Occup Environ Hyg; 2005 Oct; 2(10):508-15. PubMed ID: 16147472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating ambient concentration and cancer risk for 1,3-butadiene in Japan.
    Mita K; Higashino H; Yoshikado H; Nakanishi J
    Environ Sci; 2006; 13(1):1-13. PubMed ID: 16685248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality risk in the French cohort of uranium miners: extended follow-up 1946-1999.
    Vacquier B; Caer S; Rogel A; Feurprier M; Tirmarche M; Luccioni C; Quesne B; Acker A; Laurier D
    Occup Environ Med; 2008 Sep; 65(9):597-604. PubMed ID: 18096654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of modeled benzene exposure and dose estimates published in the Chinese-National Cancer Institute collaborative epidemiology studies.
    Budinsky RA; DeMott RP; Wernke MJ; Schell JD
    Regul Toxicol Pharmacol; 1999 Dec; 30(3):244-58. PubMed ID: 10620474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer mortality at a UK tin smelter.
    Jones SR; Atkin P; Holroyd C; Lutman E; Batlle JV; Wakeford R; Walker P
    Occup Med (Lond); 2007 Jun; 57(4):238-45. PubMed ID: 17437956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based research on occupational and environmental factors for leukemia and non-Hodgkin's lymphoma: the Northern Germany Leukemia and Lymphoma Study (NLL).
    Hoffmann W; Terschüeren C; Heimpel H; Feller A; Butte W; Hostrup O; Richardson D; Greiser E
    Am J Ind Med; 2008 Apr; 51(4):246-57. PubMed ID: 18270999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative evaluation for risk assessment of neoplasms caused by exposure to chemical substances].
    Szymczak W
    Med Pr; 2000; 51(6):625-36. PubMed ID: 11288691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.